Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19
A recent report found that rare predicted loss-of-function (pLOF) variants across 13 candidate genes in TLR3- and IRF-7 dependent type I IFN pathways explain up to 3.5% of severe COVID-19 cases. We performed whole-exome or whole genome sequencing of 1,864 COVID-19 cases (713 with severe and 1,151 wi...
Gespeichert in:
| Veröffentlicht in: | The Journal of clinical investigation Jg. 131; H. 14 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
American Society for Clinical Investigation
15.07.2021
|
| Schlagworte: | |
| ISSN: | 1558-8238, 0021-9738, 1558-8238 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | A recent report found that rare predicted loss-of-function (pLOF) variants across 13 candidate genes in TLR3- and IRF-7 dependent type I IFN pathways explain up to 3.5% of severe COVID-19 cases. We performed whole-exome or whole genome sequencing of 1,864 COVID-19 cases (713 with severe and 1,151 with mild disease) and 15,033 ancestry- matched population controls across 4 independent COVID-19 biobanks. We tested whether rare pLOF variants in these 13 genes were associated with severe COVID-19. We identified only 1 rare pLOF mutation across these genes among 713 cases with severe COVID-19 and observed no enrichment of pLOFs in severe cases compared to population controls or mild COVID-19 cases. We found no evidence of association of rare LOF variants in the 13 candidate genes with severe COVID-19 outcomes. |
|---|---|
| AbstractList | A recent report found that rare predicted loss-of-function (pLOF) variants across 13 candidate genes in TLR3- and IRF7-dependent type I IFN pathways explain up to 3.5% of severe COVID-19 cases. We performed whole-exome or whole-genome sequencing of 1,864 COVID-19 cases (713 with severe and 1,151 with mild disease) and 15,033 ancestry-matched population controls across 4 independent COVID-19 biobanks. We tested whether rare pLOF variants in these 13 genes were associated with severe COVID-19. We identified only 1 rare pLOF mutation across these genes among 713 cases with severe COVID-19 and observed no enrichment of pLOFs in severe cases compared to population controls or mild COVID-19 cases. We found no evidence of association of rare LOF variants in the 13 candidate genes with severe COVID-19 outcomes. A recent report found that rare predicted loss-of-function (pLOF) variants across 13 candidate genes in TLR3- and IRF-7 dependent type I IFN pathways explain up to 3.5% of severe COVID-19 cases. We performed whole-exome or whole genome sequencing of 1,864 COVID-19 cases (713 with severe and 1,151 with mild disease) and 15,033 ancestry- matched population controls across 4 independent COVID-19 biobanks. We tested whether rare pLOF variants in these 13 genes were associated with severe COVID-19. We identified only 1 rare pLOF mutation across these genes among 713 cases with severe COVID-19 and observed no enrichment of pLOFs in severe cases compared to population controls or mild COVID-19 cases. We found no evidence of association of rare LOF variants in the 13 candidate genes with severe COVID-19 outcomes. A recent report found that rare predicted loss-of-function (pLOF) variants across 13 candidate genes in TLR3- and IRF7-dependent type I IFN pathways explain up to 3.5% of severe COVID-19 cases. We performed whole-exome or whole-genome sequencing of 1,864 COVID-19 cases (713 with severe and 1,151 with mild disease) and 15,033 ancestry-matched population controls across 4 independent COVID-19 biobanks. We tested whether rare pLOF variants in these 13 genes were associated with severe COVID-19. We identified only 1 rare pLOF mutation across these genes among 713 cases with severe COVID-19 and observed no enrichment of pLOFs in severe cases compared to population controls or mild COVID-19 cases. We found no evidence of association of rare LOF variants in the 13 candidate genes with severe COVID-19 outcomes.A recent report found that rare predicted loss-of-function (pLOF) variants across 13 candidate genes in TLR3- and IRF7-dependent type I IFN pathways explain up to 3.5% of severe COVID-19 cases. We performed whole-exome or whole-genome sequencing of 1,864 COVID-19 cases (713 with severe and 1,151 with mild disease) and 15,033 ancestry-matched population controls across 4 independent COVID-19 biobanks. We tested whether rare pLOF variants in these 13 genes were associated with severe COVID-19. We identified only 1 rare pLOF mutation across these genes among 713 cases with severe COVID-19 and observed no enrichment of pLOFs in severe cases compared to population controls or mild COVID-19 cases. We found no evidence of association of rare LOF variants in the 13 candidate genes with severe COVID-19 outcomes. |
| Audience | Academic |
| Author | Shang, Ning Alghamdi, Bader Mbarek, Hamdi Abedalthagafi, Malak S. Scherer, Stephen W. Ragoussis, Jiannis Harthi, Fawz S. Al Alqahtani, Saleh A. Bourque, Guillaume Badji, Radja Suliman, Bandar Ali Knoppers, Bartha Almalik, Abdulaziz Strug, Lisa J. El Bardisy, Hadeel Bourgey, Mathieu Khan, Atlas Alaamery, Manal Lathrop, Mark Saad, Chadi Alghamdi, Jahad Ismail, Said I. Arabi, Yaseen M. Lepage, Pierre Abu-Safieh, Leen Jung, Junghyun Alrashed, May M. Al-Muftah, Wadha Alshareef, Abdulraheem Jones, Steven J.M. Almutairi, Mansour S. Nakanishi, Tomoko Albes, Nour Eveleigh, Robert J.M. Kiryluk, Krzysztof Al-Afghani, Hani M. Povysil, Gundula Goldstein, David B. Mooser, Vincent Mangul, Serghei Richards, J. Brent Butler-Laporte, Guillaume Aziz, Naveed Fawzy, Mohamed Zhou, Sirui Massadeh, Salam Gharavi, Ali G. Forgetta, Vincenzo Thani, Asma Al Wang, Chen Aljawini, Nora Mahmoud, Ebrahim Sabri |
| AuthorAffiliation | 15 Laboratory Department, Security Forces Hospital, General Directorate of Medical Services, Ministry of Interior, Makkah, Saudi Arabia 27 Department of Twin Research, King’s College London, London, United Kingdom 20 Division of Gastroenterology and Hepatology, Johns Hopkins University, Baltimore, Maryland, USA 22 Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia 10 McGill Genome Center, McGill University, Montréal, Québec, Canada 19 Liver Transplant Unit, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia 4 Division of Nephrology, Department of Medicine, Vagelos College of Physicians & Surgeons, Columbia University, New York, New York, USA 9 Canadian Centre for Computational Genomics, McGill University, Montréal, Québec, Canada 7 Department of Human Genetics, McGill University, Montréal, Québec, Canada 13 Saudi Biobank, King Abdullah International Medical Research Center, King Saud bin Abdulaziz Un |
| AuthorAffiliation_xml | – name: 8 Kyoto-McGill International Collaborative School in Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan – name: 17 Genomics Research Department, Saudi Human Genome Project, King Fahad Medical City and King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia – name: 15 Laboratory Department, Security Forces Hospital, General Directorate of Medical Services, Ministry of Interior, Makkah, Saudi Arabia – name: 18 College of Applied Medical Sciences, Taibah University, Madina, Saudi Arabia – name: 27 Department of Twin Research, King’s College London, London, United Kingdom – name: 14 KACST-BWH Centre of Excellence for Biomedicine, Joint Centers of Excellence Program, King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia – name: 3 Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montréal, Québec, Canada – name: 16 Ministry of the National Guard Health Affairs, King Abdullah International Medical Research Center and King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia – name: 25 Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA – name: 2 Lady Davis Institute for Medical Research, Montréal, Québec, Canada – name: 11 Canadian COVID Genomics Network, HostSeq Project, Canada – name: 7 Department of Human Genetics, McGill University, Montréal, Québec, Canada – name: 12 Canadian Centre for Computational Genomics, McGill University, Montréal, Québec, Canada – name: 13 Saudi Biobank, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia – name: 10 McGill Genome Center, McGill University, Montréal, Québec, Canada – name: 1 Institute for Genomic Medicine, Columbia University, New York, New York, USA – name: 9 Canadian Centre for Computational Genomics, McGill University, Montréal, Québec, Canada – name: 4 Division of Nephrology, Department of Medicine, Vagelos College of Physicians & Surgeons, Columbia University, New York, New York, USA – name: 19 Liver Transplant Unit, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia – name: 21 Life Science and Environmental Institute, King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia – name: 6 Saudi Human Genome Project at King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia – name: 24 Department of Clinical Pharmacy, School of Pharmacy, University of Southern California, Los Angeles, California, USA – name: 22 Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia – name: 28 Department of Genetics & Development, Columbia University, New York, New York, USA – name: 23 Qatar Genome Program, Qatar Foundation Research, Development and Innovation, Qatar Foundation, Doha, Qatar – name: 26 Center for Precision Medicine and Genomics, Department of Medicine, Vagelos College of Physicians & Surgeons, Columbia University, New York, New York, USA – name: 20 Division of Gastroenterology and Hepatology, Johns Hopkins University, Baltimore, Maryland, USA – name: 5 Developmental Medicine Department, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia |
| Author_xml | – sequence: 1 givenname: Gundula orcidid: 0000-0003-4625-5909 surname: Povysil fullname: Povysil, Gundula – sequence: 2 givenname: Guillaume orcidid: 0000-0001-5388-0396 surname: Butler-Laporte fullname: Butler-Laporte, Guillaume – sequence: 3 givenname: Ning orcidid: 0000-0001-7040-5204 surname: Shang fullname: Shang, Ning – sequence: 4 givenname: Chen orcidid: 0000-0001-9127-0054 surname: Wang fullname: Wang, Chen – sequence: 5 givenname: Atlas surname: Khan fullname: Khan, Atlas – sequence: 6 givenname: Manal surname: Alaamery fullname: Alaamery, Manal – sequence: 7 givenname: Tomoko orcidid: 0000-0001-9510-5646 surname: Nakanishi fullname: Nakanishi, Tomoko – sequence: 8 givenname: Sirui orcidid: 0000-0003-4963-0815 surname: Zhou fullname: Zhou, Sirui – sequence: 9 givenname: Vincenzo orcidid: 0000-0002-6061-4720 surname: Forgetta fullname: Forgetta, Vincenzo – sequence: 10 givenname: Robert J.M. surname: Eveleigh fullname: Eveleigh, Robert J.M. – sequence: 11 givenname: Mathieu orcidid: 0000-0002-8432-834X surname: Bourgey fullname: Bourgey, Mathieu – sequence: 12 givenname: Naveed surname: Aziz fullname: Aziz, Naveed – sequence: 13 givenname: Steven J.M. orcidid: 0000-0003-3394-2208 surname: Jones fullname: Jones, Steven J.M. – sequence: 14 givenname: Bartha surname: Knoppers fullname: Knoppers, Bartha – sequence: 15 givenname: Stephen W. surname: Scherer fullname: Scherer, Stephen W. – sequence: 16 givenname: Lisa J. orcidid: 0000-0003-0503-9740 surname: Strug fullname: Strug, Lisa J. – sequence: 17 givenname: Pierre surname: Lepage fullname: Lepage, Pierre – sequence: 18 givenname: Jiannis orcidid: 0000-0002-8515-0934 surname: Ragoussis fullname: Ragoussis, Jiannis – sequence: 19 givenname: Guillaume orcidid: 0000-0002-3933-9656 surname: Bourque fullname: Bourque, Guillaume – sequence: 20 givenname: Jahad surname: Alghamdi fullname: Alghamdi, Jahad – sequence: 21 givenname: Nora surname: Aljawini fullname: Aljawini, Nora – sequence: 22 givenname: Nour surname: Albes fullname: Albes, Nour – sequence: 23 givenname: Hani M. orcidid: 0000-0001-9307-2860 surname: Al-Afghani fullname: Al-Afghani, Hani M. – sequence: 24 givenname: Bader surname: Alghamdi fullname: Alghamdi, Bader – sequence: 25 givenname: Mansour S. surname: Almutairi fullname: Almutairi, Mansour S. – sequence: 26 givenname: Ebrahim Sabri orcidid: 0000-0002-2381-8927 surname: Mahmoud fullname: Mahmoud, Ebrahim Sabri – sequence: 27 givenname: Leen surname: Abu-Safieh fullname: Abu-Safieh, Leen – sequence: 28 givenname: Hadeel surname: El Bardisy fullname: El Bardisy, Hadeel – sequence: 29 givenname: Fawz S. Al orcidid: 0000-0003-3058-5321 surname: Harthi fullname: Harthi, Fawz S. Al – sequence: 30 givenname: Abdulraheem orcidid: 0000-0002-5117-5463 surname: Alshareef fullname: Alshareef, Abdulraheem – sequence: 31 givenname: Bandar Ali orcidid: 0000-0003-0649-3419 surname: Suliman fullname: Suliman, Bandar Ali – sequence: 32 givenname: Saleh A. orcidid: 0000-0003-2017-3526 surname: Alqahtani fullname: Alqahtani, Saleh A. – sequence: 33 givenname: Abdulaziz orcidid: 0000-0002-4656-0674 surname: Almalik fullname: Almalik, Abdulaziz – sequence: 34 givenname: May M. orcidid: 0000-0002-3056-6393 surname: Alrashed fullname: Alrashed, May M. – sequence: 35 givenname: Salam orcidid: 0000-0001-9193-0008 surname: Massadeh fullname: Massadeh, Salam – sequence: 36 givenname: Vincent surname: Mooser fullname: Mooser, Vincent – sequence: 37 givenname: Mark surname: Lathrop fullname: Lathrop, Mark – sequence: 38 givenname: Mohamed orcidid: 0000-0003-0322-2816 surname: Fawzy fullname: Fawzy, Mohamed – sequence: 39 givenname: Yaseen M. orcidid: 0000-0001-5735-6241 surname: Arabi fullname: Arabi, Yaseen M. – sequence: 40 givenname: Hamdi surname: Mbarek fullname: Mbarek, Hamdi – sequence: 41 givenname: Chadi orcidid: 0000-0001-6963-9126 surname: Saad fullname: Saad, Chadi – sequence: 42 givenname: Wadha orcidid: 0000-0003-2549-082X surname: Al-Muftah fullname: Al-Muftah, Wadha – sequence: 43 givenname: Junghyun surname: Jung fullname: Jung, Junghyun – sequence: 44 givenname: Serghei surname: Mangul fullname: Mangul, Serghei – sequence: 45 givenname: Radja orcidid: 0000-0002-0512-3312 surname: Badji fullname: Badji, Radja – sequence: 46 givenname: Asma Al surname: Thani fullname: Thani, Asma Al – sequence: 47 givenname: Said I. surname: Ismail fullname: Ismail, Said I. – sequence: 48 givenname: Ali G. orcidid: 0000-0003-2801-233X surname: Gharavi fullname: Gharavi, Ali G. – sequence: 49 givenname: Malak S. surname: Abedalthagafi fullname: Abedalthagafi, Malak S. – sequence: 50 givenname: J. Brent surname: Richards fullname: Richards, J. Brent – sequence: 51 givenname: David B. surname: Goldstein fullname: Goldstein, David B. – sequence: 52 givenname: Krzysztof orcidid: 0000-0002-5047-6715 surname: Kiryluk fullname: Kiryluk, Krzysztof |
| BookMark | eNqNkk1v1DAQhi3UirYLB_6BJSRED2nj2M7HBalaKKSqulKBXi3HmewaJfY2dpbuv8fRlrYRe0A-2PI878xo5j1BB8YaQOgdic8IyZLzq3lJWJZT9godE87zKE9ofvDifYROnPsVx4Qxzl6jI8piRnkRHyN1K3vArXUusk3UDEZ5bQ3eyF5L4x3WBvvtGnCJy8sbrLtuMNpv8RIMODxKjfVYOmeVlh5q_Fv7FXawgRCaL-7KzxEp3qDDRrYO3j7eM_Tz8suP-bfoevG1nF9cR4rz1EcUcoAYALImyXIeV7yuM8YrLqEiTVEVSnHGOZCGFUlRMUZzpdKcq5opImVNZ-jTLu96qDqoFRjfy1ase93Jfius1GIaMXollnYj8iQreJjfDH18TNDb-wGcF512CtpWGrCDEwmnLCVJxrKAvt-hS9mC0KaxIaMacXGRpgVloT0aqGgPNQ4vlA87bHT4nvBne_hwaui02is4nQgC4-HBL-XgnCi_3_4_u7ibsh9esCuQrV852w6jOdwUPN-Bqg8e6qERSns5YqFz3QoSi9Gi4smiz208Kf4u6F_2D5uU4vc |
| CitedBy_id | crossref_primary_10_1371_journal_ppat_1012786 crossref_primary_10_1002_eji_202250230 crossref_primary_10_1016_j_virusres_2024_199509 crossref_primary_10_1172_JCI149459 crossref_primary_10_1016_j_ebiom_2021_103629 crossref_primary_10_3390_v15010175 crossref_primary_10_3389_fped_2021_723532 crossref_primary_10_1016_j_gim_2024_101268 crossref_primary_10_3389_fimmu_2023_1185233 crossref_primary_10_1172_JCI156409 crossref_primary_10_1186_s13073_022_01100_3 crossref_primary_10_1097_MOP_0000000000001061 crossref_primary_10_1146_annurev_genet_080320_010449 crossref_primary_10_1016_j_coviro_2021_08_004 crossref_primary_10_3390_diagnostics15111403 crossref_primary_10_1177_15598276221123005 crossref_primary_10_1038_s41576_022_00478_5 crossref_primary_10_1016_j_lfs_2023_121940 crossref_primary_10_1038_s41588_022_01239_0 crossref_primary_10_1146_annurev_biodatasci_020222_021705 crossref_primary_10_3390_ijms24098065 crossref_primary_10_1186_s12967_022_03767_z crossref_primary_10_3390_life12091300 crossref_primary_10_1038_s41586_022_04447_0 crossref_primary_10_3390_jpm11111166 crossref_primary_10_1128_jvi_01276_23 crossref_primary_10_1001_jamanetworkopen_2022_39122 crossref_primary_10_1002_acn3_51631 crossref_primary_10_1016_j_meegid_2023_105426 crossref_primary_10_1002_cti2_1365 crossref_primary_10_3390_genes13030534 crossref_primary_10_3389_fped_2022_790273 crossref_primary_10_1002_ctd2_7 crossref_primary_10_1016_j_immuni_2022_01_014 crossref_primary_10_1038_s41598_023_47718_0 crossref_primary_10_3390_biology10090829 crossref_primary_10_1172_JCI152474 crossref_primary_10_1172_JCI152475 crossref_primary_10_3390_vaccines10101657 |
| Cites_doi | 10.1038/s41576-019-0177-4 10.1101/2021.03.10.21252820 10.1101/2020.10.28.20221804 10.1001/jamacardio.2020.6500 10.7326/0003-4819-150-3-200902030-00011 10.1126/science.abd4570 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2021 American Society for Clinical Investigation 2021 American Society for Clinical Investigation 2021 American Society for Clinical Investigation |
| Copyright_xml | – notice: COPYRIGHT 2021 American Society for Clinical Investigation – notice: 2021 American Society for Clinical Investigation 2021 American Society for Clinical Investigation |
| DBID | AAYXX CITATION IOV ISR 7X8 5PM |
| DOI | 10.1172/JCI147834 |
| DatabaseName | CrossRef Gale In Context: Opposing Viewpoints Gale In Context: Science MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1558-8238 |
| ExternalDocumentID | PMC8279578 A669344433 10_1172_JCI147834 |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GrantInformation_xml | – fundername: ; grantid: UL1TR001873 |
| GroupedDBID | --- -~X .55 .XZ 08G 08P 29K 354 36B 5GY 5RE 5RS 7RV 7X7 88E 8AO 8F7 8FE 8FH 8FI 8FJ 8R4 8R5 AAWTL AAYXX ABOCM ABPMR ABUWG ACGFO ACIHN ACNCT ACPRK ADBBV ADPDF AEAQA AENEX AFCHL AFFHD AFKRA AHMBA ALMA_UNASSIGNED_HOLDINGS AOIJS ASPBG AVWKF AZFZN BAWUL BBNVY BCU BEC BENPR BHPHI BKEYQ BLC BPHCQ BVXVI CCPQU CITATION CS3 D-I DIK DU5 E3Z EBD EBS EJD EMB EMOBN EX3 F5P FRP FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IEA IHR IHW INH IOF IOV IPO ISR ITC KQ8 L7B LK8 M1P M5~ M7P NAPCQ OBH OCB ODZKP OFXIZ OGEVE OHH OK1 OVD OVIDX OVT P2P P6G PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO Q2X RPM S0X SJFOW SV3 TEORI TR2 TVE UKHRP VVN W2D WH7 WOQ WOW X7M XSB YFH YHG YKV YOC ZY1 ~H1 ALIPV 7X8 5PM |
| ID | FETCH-LOGICAL-c556t-3e8ee0eee7f27850b5dd745b5aeb1f9b9cc5455e1f4929b4438cc685cd4c1aad3 |
| ISICitedReferencesCount | 59 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000684019100004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1558-8238 0021-9738 |
| IngestDate | Tue Nov 04 01:54:50 EST 2025 Sun Nov 09 11:07:59 EST 2025 Sat Nov 29 13:24:18 EST 2025 Sat Nov 29 11:23:57 EST 2025 Sat Nov 29 10:11:44 EST 2025 Wed Nov 26 10:14:35 EST 2025 Wed Nov 26 10:30:08 EST 2025 Thu May 22 20:42:36 EDT 2025 Tue Nov 18 20:59:45 EST 2025 Sat Nov 29 01:34:36 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 14 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c556t-3e8ee0eee7f27850b5dd745b5aeb1f9b9cc5455e1f4929b4438cc685cd4c1aad3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-0512-3312 0000-0003-2017-3526 0000-0002-5117-5463 0000-0003-0322-2816 0000-0003-3394-2208 0000-0001-5388-0396 0000-0002-8515-0934 0000-0003-0503-9740 0000-0002-3056-6393 0000-0002-6061-4720 0000-0001-9307-2860 0000-0001-7040-5204 0000-0003-3058-5321 0000-0001-9193-0008 0000-0001-9127-0054 0000-0003-0649-3419 0000-0001-6963-9126 0000-0003-2801-233X 0000-0003-4625-5909 0000-0002-2381-8927 0000-0001-9510-5646 0000-0001-5735-6241 0000-0003-4963-0815 0000-0002-4656-0674 0000-0002-3933-9656 0000-0002-5047-6715 0000-0002-8432-834X 0000-0003-2549-082X |
| OpenAccessLink | http://www.jci.org/articles/view/147834/files/pdf |
| PMID | 34043590 |
| PQID | 2534612747 |
| PQPubID | 23479 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8279578 proquest_miscellaneous_2534612747 gale_infotracmisc_A669344433 gale_infotracgeneralonefile_A669344433 gale_infotracacademiconefile_A669344433 gale_incontextgauss_ISR_A669344433 gale_incontextgauss_IOV_A669344433 gale_healthsolutions_A669344433 crossref_citationtrail_10_1172_JCI147834 crossref_primary_10_1172_JCI147834 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-07-15 |
| PublicationDateYYYYMMDD | 2021-07-15 |
| PublicationDate_xml | – month: 07 year: 2021 text: 2021-07-15 day: 15 |
| PublicationDecade | 2020 |
| PublicationTitle | The Journal of clinical investigation |
| PublicationYear | 2021 |
| Publisher | American Society for Clinical Investigation |
| Publisher_xml | – name: American Society for Clinical Investigation |
| References | B3 B4 B5 B6 Povysil (B2) 2020; 6 B1 |
| References_xml | – ident: B6 doi: 10.1038/s41576-019-0177-4 – ident: B3 doi: 10.1101/2021.03.10.21252820 – ident: B4 doi: 10.1101/2020.10.28.20221804 – volume: 6 start-page: 379 issue: 4 year: 2020 ident: B2 article-title: Assessing the role of rare genetic variation in patients with heart failure publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2020.6500 – ident: B5 doi: 10.7326/0003-4819-150-3-200902030-00011 – ident: B1 doi: 10.1126/science.abd4570 |
| SSID | ssj0014454 |
| Score | 2.5730858 |
| Snippet | A recent report found that rare predicted loss-of-function (pLOF) variants across 13 candidate genes in TLR3- and IRF-7 dependent type I IFN pathways explain... A recent report found that rare predicted loss-of-function (pLOF) variants across 13 candidate genes in TLR3- and IRF7-dependent type I IFN pathways explain up... |
| SourceID | pubmedcentral proquest gale crossref |
| SourceType | Open Access Repository Aggregation Database Enrichment Source Index Database |
| SubjectTerms | Concise Communication Genetic aspects Genetic research Genetic variation Health aspects Interferon |
| Title | Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19 |
| URI | https://www.proquest.com/docview/2534612747 https://pubmed.ncbi.nlm.nih.gov/PMC8279578 |
| Volume | 131 |
| WOSCitedRecordID | wos000684019100004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1558-8238 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0014454 issn: 1558-8238 databaseCode: M7P dateStart: 20020701 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection (Proquest) customDbUrl: eissn: 1558-8238 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0014454 issn: 1558-8238 databaseCode: 7X7 dateStart: 20020701 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database (ProQuest) customDbUrl: eissn: 1558-8238 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0014454 issn: 1558-8238 databaseCode: 7RV dateStart: 20020701 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central - New (Subscription) customDbUrl: eissn: 1558-8238 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0014454 issn: 1558-8238 databaseCode: BENPR dateStart: 20020701 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfKhhAviE9RGMUgBEiVtTUftfMIZRNBo6u6UfUtShynKyrJ1C_tf-Kf5C52kqb0oTzwElXxJXF9v9ydnbufCXnniRBhYTOwkDFDinMmPBWzxLZjZHsRIs5JXM95vy_GY2_QaPwuamHWM56m4vbWu_mvqoZzoGwsnf0HdZc3hRPwG5QOR1A7HPdS_BBzuWbg-1iWMHRbuYbXMCfOU14wrxGXXf22f9ZvT_PyEAjEJ2jz2nhpmuHmM1ppRW46uE8FTb2Lkf-FGePzs8LZRlRbVlpOKwKP6kv_IFsDLPSeXqs0Xs2q5QBMTJqz8zAnWtcCuCHS6leJvMtibbtfuNv8Q4A-17s2NW1mBcPq4NKoruHcKBpAa7aRp9oreuv_1duiCqHDPK6ZYUpLbhyKgayz20VwpJz91vM7Di8WUms03P7FqH5S0wN3u57tOI5t3yGHFnc9NKF8XM7uYWLqGspv3TFDYwWPOy4fVgt-tkOA7bTcjTjn6iF5YFRJP2lgPSINlT4m976bFIwnRCK-6Da-aIEvOk0p4ov6FPBFC3zRHF8ULwV80QpfFPFFNb5oga-n5MfZ6VXvKzM7dTDput0ls5VQ6kQpxROLC_ckcuOYO27khhAKJF7kSQmRuqs6iQPheASjKKTsClfGjuyEYWw_IwdplqrnhCZwVTdCC6JCxxVRpLxEysRyVGJbthc1ycdiCANpaOxxN5VZkE9nuRWUo90kb0vRG83dskvoNeoh0GXHpQEIKn3DbXIJZEtJMR1rEq4WiwBgsofQ5bAm9MEIJRn0WYamBAb-ObKw1STf1yQnmoN-l-BRTRCcg6w1vyngFWATZlSmKlstAsu1HZjdcIc3Ca_hrhwrZJ6vt6TT65yBXljcA1f_Yp-ReUnuVy_9ETlYzlfqFbkr18vpYt6Cd2g4auVvUn4ULXL4-bQ_GLYwC3vwB_O7ADY |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rare+loss-of-function+variants+in+type+I+IFN+immunity+genes+are+not+associated+with+severe+COVID-19&rft.jtitle=The+Journal+of+clinical+investigation&rft.au=Povysil%2C+Gundula&rft.au=Butler-Laporte%2C+Guillaume&rft.au=Shang%2C+Ning&rft.au=Wang%2C+Chen&rft.date=2021-07-15&rft.pub=American+Society+for+Clinical+Investigation&rft.issn=0021-9738&rft.volume=131&rft.issue=14&rft_id=info:doi/10.1172%2FJCI147834&rft.externalDBID=IOV&rft.externalDocID=A669344433 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1558-8238&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1558-8238&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1558-8238&client=summon |